Get AI Ready Launches Global AI & Data Transformation Consultancy Across Sydney, Singapore and London
The Databricks Delivery partner has appointed ex-Accenture & Salesforce executive Brett Raven to lead the business and has added a senior advisory board. SYDNEY... Read more.
Navan Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO–(BUSINESS WIRE)–$NAVN #Navan–Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Navan, Inc. (NASDAQ: NAVN).... Read more.
Thrust Flight Gives Students a High-Flying Edge With New Aerobatic Program and Team
New program equips student pilots with advanced aerobatic skills, hands-on upset recovery training and a pathway to competitive flying that prepares them for high-level... Read more.
Get AI Ready Launches Global AI & Data Transformation Consultancy Across Sydney, Singapore and London
The Databricks delivery partner has appointed former Accenture and Salesforce executive Brett Raven to lead the business, supported by a senior advisory board. SYDNEY... Read more.
Master Plan Communications Launches Material Handling Marketing Insights Video Series: “Handle More Business”
Tips on Maximizing ROI at MODEX 2026 in Inaugural “Handle More Business” Video IRVING, Texas & RANCHO SANTA MARGARITA, Calif.–(BUSINESS WIRE)–Master... Read more.
ESS Appoints Randall Selesky as Chief Commercial Officer to Accelerate Global Growth
Veteran Energy Storage Commercial Leader to Drive Global Commercial Execution as ESS Strengthens Leadership Team and Scales Deployments WILSONVILLE, Ore.–(BUSINESS... Read more.
I/O Fund Proves Leadership in AI Stocks with 326% Cumulative Return and 29.2% Annualized Return
BOULDER, Colo.–(BUSINESS WIRE)–$BE #Bitcoin–The I/O Fund has achieved a 326% cumulative return since its May 2020 debut, representing a 4.26x multiple.... Read more.
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis
MALVERN, Pa.–(BUSINESS WIRE)–NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics... Read more.
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure Despite... Read more.
Keysight Introduces Infiniium XR8 Oscilloscopes to Accelerate High-Speed Digital Validation and Compliance
Next-generation architecture delivers faster analysis, clearer insights, and a compact design to turn days of digital validation into hours SANTA ROSA, Calif.–(BUSINESS... Read more.